Verification of mechanism that CSC markers are implicated in poor prognosis for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Arima, K. [1 ]
Ishimoto, T. [1 ]
Ohmuraya, M. [2 ]
Okabe, H. [1 ]
Kitano, Y. [1 ]
Yamamura, K. [1 ]
Kaida, T. [1 ]
Nakagawa, S. [1 ]
Imai, K. [1 ]
Hashimoto, D. [1 ]
Chikamoto, A. [1 ]
Yamashita, Y-I [1 ]
Baba, H. [1 ]
机构：
[1] Kumamoto Univ, Dept Gastroenterol, Kumamoto, Japan
[2] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Verification of mechanism that CSC markers are implicated in poor prognosis for pancreatic ductal adenocarcinoma
    Arima, Kota
    Ishimoto, Takatsugu
    Okabe, Hirohisa
    Kitano, Yuki
    Inoue, Risa
    Yamamura, Kensuke
    Kaida, Takayoshi
    Higashi, Takaaki
    Taki, Katsunobu
    Imai, Katsunori
    Hashimoto, Daisuke
    Chikamoto, Akira
    Beppu, Toru
    Baba, Hideo
    CANCER RESEARCH, 2016, 76
  • [2] Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
    Saukkonen, Kapo
    Hagstrom, Jaana
    Mustonen, Harri
    Juuti, Anne
    Nordling, Stig
    Fermer, Christian
    Nilsson, Olle
    Seppanen, Hanna
    Haglund, Caj
    PLOS ONE, 2015, 10 (06):
  • [3] Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma
    Zhang, Shi-Rong
    Li, Hao
    Wang, Wen-Quan
    Jin, Wei
    Xu, Jin-Zhi
    Xu, Hua-Xiang
    Wu, Chun-Tao
    Gao, He-Li
    Li, Shuo
    Li, Tian-Jiao
    Zhang, Wu-Hu
    Xu, Shuai-Shuai
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Lang
    EJSO, 2019, 45 (05): : 769 - 775
  • [4] Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma
    Luo, Yanli
    Qiu, Zhengjun
    Tian, Ling
    Zhu, Guanghui
    Feng, Ye
    Yi, Miaoying
    Chen, Xiafang
    Wang, Liwei
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (01) : 69 - 76
  • [5] Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis
    Lu, Y.
    Kim, L.
    Frederick, B.
    Zhang, M.
    Liao, J.
    Talamonti, M.
    Bentrem, D.
    Rao, S. M.
    Yang, G. Y.
    LABORATORY INVESTIGATION, 2008, 88 : 310A - 310A
  • [6] Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis
    Lu, Y.
    Kim, L.
    Frederick, B.
    Zhang, M.
    Talamonti, M.
    Bentrem, D.
    Rao, S. M.
    Yang, G. Y.
    MODERN PATHOLOGY, 2008, 21 : 310A - 310A
  • [7] Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma
    Jiang, Bing
    Gu, Yonghong
    Chen, Yuxiang
    CANCER INVESTIGATION, 2014, 32 (06) : 218 - 225
  • [8] Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma
    Tang, Rui
    Ji, Jianmei
    Ding, Jun
    Huang, Jinxin
    Gong, Biao
    Zhang, Xiwen
    Li, Fu
    CELL CYCLE, 2020, 19 (13) : 1602 - 1610
  • [9] DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma
    Sun, Jie
    Bi, Fangfang
    Yang, Yang
    Zhang, Yuan
    Jin, Aihua
    Li, Jinzi
    Lin, Zhenhua
    ONCOLOGY REPORTS, 2017, 37 (02) : 857 - 864
  • [10] Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma
    Martin Tobi
    Mijin Kim
    Douglas H. Weinstein
    Mary Ann Rambus
    James Hatfield
    N. Volkan Adsay
    Edi Levi
    Douglas Evans
    Michael J. Lawson
    Suzanne Fligiel
    Digestive Diseases and Sciences, 2013, 58 : 744 - 750
12345